Navigation Links
FDA Accepts for Filing the Humanitarian Device Exemption Application For EMulate Therapeutics™ Hælo™ Pediatric System
Date:6/18/2019

EMulate Therapeutics, Inc., a clinical-stage therapeutic device company developing non-invasive treatments for cancers and other serious diseases, announced it has received notice that the US Food and Drug Administration (FDA) accepted for filing the EMulate Therapeutics application for Humanitarian Device Exemption (HDE) for the Hælo Pediatric system. The FDA granted the Humanitarian Use Device (HUD) designation for the Hælo Pediatric system in March 2018 to treat diffuse midline glioma (DMG), including diffuse intrinsic pontine glioma (DIPG), in children.

Chris Rivera, EMulate Therapeutics President and Chief Executive Officer, made the announcement stating, “This is another important step for our company. Upon the HDE approval anticipated later this year, we will be able to begin commercialization of the Hælo Pediatric system in the US to treat DMG. Most importantly, we are on our way to providing a potential treatment for children with this aggressive and uniformly fatal condition.”

Donna Morgan Murray, Chief Regulatory Officer for EMulate, stated, “DMG, including DIPG, is an ultra-rare brain tumor that primarily effects children between the ages of 5 and 10 years of age. The median survival is less than 1 year following diagnosis. It is gratifying that we have the potential to bring this new and unique treatment to children suffering from this devastating disease.”

About EMulate Therapeutics
Headquartered in Seattle, EMulate Therapeutics is a clinical-stage therapeutic device company. EMulate has invented and patented a groundbreaking technology that utilizes precisely targeted ultra-low radiofrequency energy (ulRFE®) to specifically regulate metabolic pathways on the molecular and genetic levels – without chemicals, radiation or drugs – delivered via a simple-to-use non-sterile, non-invasive, non-thermal, non-ionizing investigational device. The company’s goal is to transform disease treatment on a global scale with ulRFE, which can potentially be applied to a wide range of medical conditions as well as to veterinary medicine and non-medical applications. EMulate’s initial focus is on the treatment of patients with brain cancer, who are not well served by conventional standard of care therapies, which often result in poor outcomes and devastating side effects. Pre-clinical work is focused on exploring new applications in oncology. In addition, EMulate’s Voyager system for adults with glioblastoma is an investigational medical device in clinical development.

Media Relations Contact:
Dennis Kroft
dkroft(at)emulatetx.com
201-602-8354

Read the full story at https://www.prweb.com/releases/fda_accepts_for_filing_the_humanitarian_device_exemption_application_for_emulate_therapeutics_hlo_pediatric_system/prweb16385042.htm.


'/>"/>
Source: PRWeb
Copyright©2019 Vocus, Inc.
All rights reserved


Related medicine news :

1. Dr. Kevin Hogan Accepts New Patients with Missing Teeth for Dental Implants in Mt. Pleasant, SC, to Support Self Improvement Month
2. Periodontist, Dr. Curry Leavitt Accepts New Patients for All-on-4® Dental Implants in Las Vegas, NV
3. Newly Appointed President of Wisdom Natural Brands® Accepts Prestigious Recognition
4. Dr. Kim Ross Recognizes Stroke Awareness Month, Accepts New Patients with Periodontal Disease Annapolis, MD
5. East LA Dental Office, Smiles LA, Now Accepts New Patients With a Special Promotion
6. New Vitae Wellness and Recovery Now Accepts Waivers for Payment
7. The Nanotechnology Startup Challenge in Cancer Accepts 28 Teams to Launch Startups from Unlicensed NIH Inventions
8. Dr. Mason Miner Now Accepts New Patients from Cortez, CO, for Minimally-Painful Infant Frenectomy Laser Treatment
9. Dr. Frederick Thurston Now Accepts New Patients From Winter Haven, FL, In Need of Dental Implants
10. Dr. Joseph Gaspari Now Accepts New Allentown, PA Patients for Dental Implants
11. Dr. Kenneth Peavy Now Accepts New Gum Disease Patients From Greensboro, NC for Laser Treatment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/18/2019)... , ... July 18, 2019 , ... LEAD Hospitality Group ... organized by the Epilepsy Foundation of Georgia. The event is scheduled to take place ... Building 4 at Concourse Parkway, right under the King & Queen Buildings. LEAD Hospitality ...
(Date:7/18/2019)... ... July 18, 2019 , ... Dr. Todd Britten says he ... order to accurately address concerns brought to him by his patients. A recent news ... been brought to his attention by patients in his Clearwater, Florida practice. Dental ...
(Date:7/18/2019)... ... July 18, 2019 , ... Gateway Genomics , a leading ... new publication titled, “ Accurate Fetal Sex Determination from Maternal Blood at 8 Weeks ... DNA blood samples were collected from 108 women at an average gestational age of ...
(Date:7/17/2019)... ... July 17, 2019 , ... Guruji Mahendra Trivedi, founder of ... today’s issues affecting humanity at practical and spiritual levels. Guruji Mahendra Trivedi announces ... 20, 2019. , Guruji Mahendra Trivedi offers these powerful workshops to deepen the ...
(Date:7/17/2019)... ... 2019 , ... The Blackboard Catalyst Award in Teaching and ... honor is given to distance learning courses and programs that help set the ... from around the world that produce exemplary educational and training opportunities. Winners in ...
Breaking Medicine News(10 mins):
(Date:7/17/2019)... , ... July 17, 2019 , ... The American Psychiatric ... Board of Directors and 2020 Nominating Committee . Elected by psychiatric-mental health nurse members ... APNA 33rd Annual Conference in New Orleans, LA, October 2-5, 2019. , “These ...
(Date:7/17/2019)... (PRWEB) , ... July 17, 2019 , ... ... profession, recently tapped First American as its payment processor of record. , ... who use the Halcyon business management platform can now also accept and process ...
(Date:7/17/2019)... ... ... SmartLinx, a leader in workforce management solutions, today announced a product expansion ... them to take control of their schedules and quickly close scheduling gaps. , ... work -- highly engaged business units realize a 41% reduction in absenteeism and a ...
Breaking Medicine Technology: